No description available.

This thesis investigates the effects of low oxygen culture conditions and fibroblast growth factor-2 (FGF2) on adult human dermal fibroblasts. It was previously shown that low oxygen and FGF2 culture conditions lead to an extension of proliferative lifespan, low-level activation of stem cell genes, and global transcriptional changes in adult human dermal fibroblasts. Additionally, an increased in vivo tissue regenerative response can be observed when human muscle-derived fibroblasts grown with FGF2 and low oxygen are implanted into mouse muscle injury, leading to a decrease in collagen deposition and scar formation and increase of functional skeletal muscle regeneration, including formation of Pax7+ muscle stem cells. These findings led to an analysis of key cellular oxygen sensors, hypoxia inducible factors (HIFs) and their role in this regenerative response. Directly linking these factors with the regenerative response, I have shown, with knockdown experiments, that HIF-2α is required for the increased proliferative capability and decreased senescence of human dermal fibroblasts (hDFs) induced by hypoxia. I have also determined that low oxygen causes an early and transient increase of HIF-1α and late and sustained increase of HIF-2α protein accompanied by increased nuclear translocation. Using overexpression and knockdown approaches via lent-virus, I determined that HIF-2α appears to modulate FGF2 signaling through the FGF receptors. First, under low oxygen conditions, exogenous FGF2 led to downregulation of endogenous FGF2, which can be mimicked by overexpression of HIF-2α. In ambient oxygen we didn't see this effect. Second, HIF-2α overexpression appears to lead to increases in FGFR1 phosphorylation and consequently increased ERK1/2 phosphorylation, and increases in the expression of heparan sulfate modifying enzymes (NDST1, NDST2, and EXTL2). Lastly, sustained supplementation with FGF2 in low oxygen inhibits receptor-mediated FGF2 signaling. To understand these effects at the transcriptional level, using microarray technology, we identified oxygen-mediated FGF2 effects on genes involved in cell survival and proliferation. Through bioinformatics analyses, I determined that genes involved in wound healing (extracellular matrix genes, adhesion molecules, cytokines) are upregulated in FGF2 treated fibroblasts grown under low oxygen. By utilizing a gain-of-function approach, we were able to assess the effects of altered HIF-2α activity on the expression of Oct4, Sox2, Nanog, Rex1, and Lin28 in adult hDFs. The results indicate that overexpression of the HIF-2α transcription factor increases Oct4 mRNA, but not Oct4 protein, levels, and had no effect on Nanog and Lin28 proteins. HIF-2α overexpression also mediated FGF2 induction of Sox2 and Rex1 proteins of higher molecular weight. This thesis expands our knowledge about effects of low oxygen and FGF2 on adult human dermal fibroblasts and explains in part, how FGF2 under low oxygen conditions may lead to increased proliferation, extended life span, regenerative competency and increased developmental plasticity of adult hDFs.

Les dommages de l’ADN interfèrent avec sa réplication et sa transcription. Ils sont en général éliminés par des mécanismes de réparation, en particulier par la réparation par excision de nucléotides (NER). Ils peuvent également être tolérés grâce à la synthèse translésionnelle (TLS). Au cours de mon travail de thèse, nous avons étudié l’implication de la voie NER et de l’ADN polymérase η (Polη) associée à la TLS dans la réponse aux lésions de l’ADN induites par les rayons ultraviolet (UV) et par une drogue chimiothérapeutique, la doxorubicine. Les principales lésions induites par les rayons UV sont les dimères de pyrimidine cyclobutane (CPDs) et les pyrimidines (6-4) pyrimidones (6-4PPs) qui sont éliminées par la NER. Les données obtenues sur la formation de régions d’ADN simple brin et celles du cycle cellulaire suggèrent que les lésions 6-4PPs sont tolérées par un mécanisme de réparation post-réplicative dans des cellules XP-C déficientes en NER (xeroderma pigmentosum du groupe C). Dans un second temps, mon objectif a été de déterminer la contribution de Polη dans la prise en charge des lésions induites par les rayons UV dans les cellules XP-C. En effet, il est connu que Polη est responsable de la réplication des CPDs, mais l’absence de Polη dans des cellules proficientes en NER ne les rend pas hypersensibles aux rayons UV. De plus, il a été suggéré que Polη soit impliquée dans la TLS des 6-4PPs. En réprimant par shARN l’expression du gène codant Polη dans les cellules XP-C, j’ai réussi à établir la première lignée stable de fibroblastes humains déficients à la fois en NER et en Polη (XP-C/PolηKD). Cette réduction fonctionnelle de l’expression de Polη dans les cellules XP-C irradiées à faible dose d’UV a entraîné un arrêt irréversible du cycle cellulaire, la génération de cassures simple- et double-brin de l’ADN et une mortalité cellulaire significative. Ces résultats montrent un rôle crucial de Polη dans la survie des cellules déficientes en NER après irradiation UV et suggèrent que Polη puisse participer aussi à la TLS des 6-4PPs.Par ailleurs, nous avons montré que les cellules déficientes en NER ou en Polη ont été sensibilisées par un traitement à la doxorubicine indiquant que la NER et Polη participent également de la prise en charge des lésions induites par cet agent. Donc au cours de mon travail de thèse, j’ai mis en évidence des interconnexions complexes entre Polη et la voie NER en réponses à différents agents génotoxiques. / DNA damages interfere with replication and transcription. They are normally eliminated by repair mechanisms, such as nucleotide excision repair (NER). They can also be tolerated by translesion DNA synthesis (TLS). During my PhD work, we studied the involvement of NER pathway and DNA polymerase η (Polη) associated with TLS in response to DNA damages induced by ultraviolet (UV) and a chemotherapeutic drug, doxorubicin.The main lesions induced by UV irradiation are cyclobutane pyrimidine dimers (CPDs) and pyrimidine (6-4) pyrimidones (6-4PPs) which are removed by NER. Data on the formation of single-stranded DNA regions and those of the cell cycle suggest that 6-4PPs lesions are tolerated by a post-replication repair mechanism in XP-C cells (xeroderma pigmentosum group C, deficient in NER). In a second time, my goal was to determine the contribution of Polη in the tolerance of lesions induced by UV in XP-C cells. Indeed, it is known that Polη is responsible for the replication of CPDs, but in the absence of Polη, NER-proficient cells are not hypersensitive to UV rays. In addition, it was suggested that Polη is also involved in the TLS of 6-4PPs. By knocking down (KD) the expression of the gene encoding Polη in XP-C cells with a shRNA, we established the first stable line of human fibroblasts deficient in both NER and Polη (XP-C/PolηKD). This functional reduction in the expression of Polη in XP-C cells irradiated with low UVC dose resulted in an irreversible cell cycle arrest, the generation of single- and double-strand DNA breaks and significant cell death. These data demonstrate a crucial role for Polη in the survival of NER-deficient cells after UV irradiation and suggest that Polη can also participate in the TLS of 6-4PPs.In addition, we showed that cells deficient in NER or Polη are sensitized by treatment with doxorubicin indicating that NER and Polη also participate in the response of DNA damages induced by this agent.In conclusion, during my PhD work, we highlighted the complex interconnections between Polη and NER pathway in response to different genotoxic agents. / Os danos do DNA interferem com a sua replicação e transcrição. Eles são normalmente removidos por mecanismos de reparo, como o reparo por excisão de nucleotídeos (NER). Lesões não removidas também podem ser toleradas por processos específicos de síntese de translesão (TLS). Durante este trabalho de tese, estudamos a implicação da via NER e da DNA polimerase η (Polη), associada à TLS, na resposta aos danos no DNA provocados pela irradiação ultravioleta (UV) e por um agente quimioterápico, a doxorrubicina.As principais lesões provocadas pela luz UV são os dímeros de pirimidina ciclobutano (CPDs) e as pirimidinas (6-4) pirimidonas (6-4PPs) que são removidas pelo NER. Os resultados obtidos sobre a formação de regiões de DNA simples fita e os dados de ciclo celular indicam que as lesões 6-4PPs são toleradas por un mecanismo de reparo pós-replicativo em células XP-C deficientes em NER (xeroderma pigmentosum do grupo C). Em seguida, buscamos determinar a contribuição da Polη na tolerância de lesões UV em células XP-C. De fato, é conhecido que a Polη é responsável pela replicação dos CPDs, porém a ausência dessa em células proficientes em NER não as torna hypersensíveis à irradiação UV. Além disso, foi sugerido que Polη poderia estar envolvida na TLS dos 6-4PPs. A expressão do gene POLH, que codifica Polη, foi silenciada através de shRNA em células XP-C, sendo assim estabelecida a primeira linhagem estável de fibroblastos humanos deficientes em ambas proteínas XPC e Polη. Essa redução funcional da expressão de Polη em células XP-C provocou, em células irradiadas com doses baixas de luz UV, uma parada irreversível no ciclo celular, a formação de quebras no DNA (incluindo quebras simples e dupla fita) e morte celular. Esses resultados revelam um papel crucial da Polη na sobrevida das células deficientes em NER após irradiação UV e sugerem que Polη possa também participar da TLS de lesões tipo 6-4PP.Por outro lado, participei de trabalho no qual demonstramos que células deficientes em NER ou em Polη são sensibilizadas pelo tratamento com doxorrubicina, o que indica que o NER e a Polη participam da resposta aos danos induzidos por esse agente.Em conclusão, ao longo do meu trabalho de tese, eu coloquei em evidência interconexões complexas entre a Polη e o NER em resposta a diferentes agentes genotóxicos.

O excesso de tecido cicatricial (quelóides e cicatrizes hipertróficas) é um defeito do processo de cicatrização das feridas, caracterizado por um aumento na produção da matriz extracelular. Neste estudo, fibroblastos dérmicos humanos tratados com 50 <font face=\"symbol\">mM verapamil apresentaram discreta modificação na distribuição dos microfilamentos e alteraram sua morfologia de fusiformes para estrelados/arredondados. Estes efeitos poderiam estar associados a baixos níveis de cálcio citosólico. Esta hipótese foi confirmada através marcação de fibroblastos tratados com calcium green. Observamos também, que o verapamil inibiu a proliferação celular em 64,4%, aumentou a secreção de MMP1 e diminuiu o colágeno sintetizado pelos fibroblastos, sem aparentes efeitos citotóxicos. O metabolismo celular do cálcio está aparentemente relacionado a produção da matriz extracelular e portanto as patologias hipertróficas da cicatrização (quelóides e cicatrizes hipertróficas) podem responder ao tratamento com bloqueadores do canal de cálcio (verapamil). / Excessive scar tissue (keloids and hypertrophic scars) is a defective wound healing process characterized by overproduction of extracellular matrix. In the present study human dermal fibroblasts treated with 50 <font face=\"symbol\">mM verapamil changed their normal spindle-shaped morphology to stellate/rounded and showed discrete reorganization of microfilaments We hypothesized that these effects would be associated to lower levels of cytosolic Ca2+. Indeed, short time loading with calcium green confirmed that verapamil-treated fibroblasts exhibited lower intracellular calcium levels. We also observed that verapamil decrease cellular proliferation by 64.4%, increase the secretion of MMP1 and decrease synthesis of collagen in cultured fibroblasts. This alterations induced by verapamil are not associated with cytotoxic effects. The cellular calcium metabolism appears to regulate extracellular matrix production and so those hypertrophic disorders of wound healing (keloids and hypertrophic scars) may respond to therapy with calcium antagonist drugs (verapamil).

O excesso de tecido cicatricial (quelóides e cicatrizes hipertróficas) é um defeito do processo de cicatrização das feridas, caracterizado por um aumento na produção da matriz extracelular. Neste estudo, fibroblastos dérmicos humanos tratados com 50 <font face=\"symbol\">mM verapamil apresentaram discreta modificação na distribuição dos microfilamentos e alteraram sua morfologia de fusiformes para estrelados/arredondados. Estes efeitos poderiam estar associados a baixos níveis de cálcio citosólico. Esta hipótese foi confirmada através marcação de fibroblastos tratados com calcium green. Observamos também, que o verapamil inibiu a proliferação celular em 64,4%, aumentou a secreção de MMP1 e diminuiu o colágeno sintetizado pelos fibroblastos, sem aparentes efeitos citotóxicos. O metabolismo celular do cálcio está aparentemente relacionado a produção da matriz extracelular e portanto as patologias hipertróficas da cicatrização (quelóides e cicatrizes hipertróficas) podem responder ao tratamento com bloqueadores do canal de cálcio (verapamil). / Excessive scar tissue (keloids and hypertrophic scars) is a defective wound healing process characterized by overproduction of extracellular matrix. In the present study human dermal fibroblasts treated with 50 <font face=\"symbol\">mM verapamil changed their normal spindle-shaped morphology to stellate/rounded and showed discrete reorganization of microfilaments We hypothesized that these effects would be associated to lower levels of cytosolic Ca2+. Indeed, short time loading with calcium green confirmed that verapamil-treated fibroblasts exhibited lower intracellular calcium levels. We also observed that verapamil decrease cellular proliferation by 64.4%, increase the secretion of MMP1 and decrease synthesis of collagen in cultured fibroblasts. This alterations induced by verapamil are not associated with cytotoxic effects. The cellular calcium metabolism appears to regulate extracellular matrix production and so those hypertrophic disorders of wound healing (keloids and hypertrophic scars) may respond to therapy with calcium antagonist drugs (verapamil).

There is an increasing interest for the use of nanostructures as potential tools in areas that include biology and medicine, for applications spanning from cell separation to treatments of diseases. Magnetic nanoparticles (MNPs) have been the most widely studied and utilized nanostructures in biomedical applications. Despite their popularity, the regular shape of MNPs limits their potential for certain applications. Studies have shown that magnetic nanowires (MNWs), due to their high-­-aspect ratio and specific magnetic properties, might provide improved performance for some biomedical applications. As a consequence, MNWs have received increasing attention from researchers in the last years. However, as with any other nanostructure intended for biomedical applications, rigorous studies must be carried out to determine their potential toxicity and adverse effects before they can be successfully incorporated in clinical applications. This work attempts to elucidate the cytotoxic effects of nickel NWs (Ni NWs) in human fibroblasts by measuring cell viability under different parameters. Ni NWs of three different lengths (0.86 ± 0.02 μm, 1.1 ± 0.1 μm and 6.1 ± 0.6 μm) were fabricated by electrodeposition using porous aluminum oxide (PAO) membranes as templates. Energy dispersive X-­-Ray analysis (EDAX) and X-­-Ray diffraction (XRD) were used for the chemical characterization of the Ni NWs. Their physical characterization was done using scanning electron microscopy (SEM) and transmission electron microscopy (TEM) imaging. MTT assays were performed to assess cell viability of human fibroblasts in the presence of Ni NWs. NW length, NW/cell ratio and exposure time were changed throughout the experiments to elucidate their effects on cell viability. The results showed that NWs length has a strong effect on internalization and cytotoxicity. Smaller NWs showed higher toxicity levels at earlier times while longer NWs had stronger effects on cell viability at later times. NW/cell ratio did not seem to have a very strong effect at low concentrations. However, at high concentration (1000 NW/cell) significant loss of cell viability was observed, with the effects becoming stronger at later times. Other factors such as cell surface area, presence of oxide layer on NWs, and the cytotoxicity of Ni salts, were also studied and found to affect cell viability. For our knowledge, this is the first systematic study done in human fibroblasts wi-­-38 using ferromagnetic NWs; where the toxic effects of equivalent amounts of Ni in its salt and in its NW form are compared. It is also the first study to provide insights of the interaction between wi-­-38 cells and Ni NWs. The results of this study complement and enrich previous cytotoxicity studies of Ni NWs. This work aims at providing a more comprehensive understanding of the interaction between NWs and biological systems. Despite the advancements, further studies will be required to fully understand the factors affecting NW cytotoxicity. Only when we understand the underlying mechanisms, will we be able to design suitable nanostructures for biomedical applications.

La maladie de Parkinson (MP) est une pathologie neurodégénérative fréquente. Différents mécanismes moléculaires ont été mis en cause, dont une dysfonction mitochondriale. Des mutations du gène LRRK2, codant la protéine leucine-rich repeat kinase 2, sont responsables de formes autosomiques dominantes. La substitution la plus fréquente, G2019S, confère à la protéine un gain de fonction. LRRK2 semble réguler l’homéostasie mitochondriale, rôle initialement attribué aux protéines Parkine et PINK1, qui régulent en particulier la mitophagie. Nous avons étudié le rôle de LRRK2 et de son variant LRRK2-G2019S dans la régulation de la mitophagie dépendante de PINK1/Parkine. Nous avons également évalué l’effet de l’activité kinase sur ce processus dans un modèle cellulaire et dans des fibroblastes de patients. Nous avons exploré l’effet de LRRK2 sur la régulation d’interactions protéiques essentielles dans la mitophagie. Enfin, nous avons comparé l’efficacité de la mitophagie dans les formes familiales de la MP liées aux gènes LRRK2 et PARK2. Nous avons montré que LRRK2 et son variant LRRK2 G2019S retardent la mitophagie. Au travers de son activité kinase, LRRK2 compromet des interactions protéiques clefs impliquant Parkine et la GTPase Drp1. Nous avons mis en évidence un défaut de ce processus dans les fibroblastes de patients porteurs de mutations du gène PARK2. Ce défaut est également retrouvé dans les fibroblastes de patients porteurs de la substitution G2019S, dans lesquels il est corrigé par l’inhibition de l’activité kinase de la protéine. Ces résultats mettent en évidence un rôle de LRRK2 et de sa substitution pathogène dans la mitophagie dépendante de la voie PINK1/Parkine. / Parkinson’s disease (PD) is a frequent neurodegenerative disorder. Different molecular mechanisms are suspected, among which mitochondrial dysfunction stands out. Mutations in LRRK2, encoding leucine-rich repeat kinase 2 (LRRK2), cause autosomal dominant PD forms. The most frequent G2019S substitution leads to a gain of function. LRRK2 seems to modulate mitochondrial homeostasis, initially associated with Parkin and PINK1 proteins, which regulate in particular mitophagy. Here, we explored the involvement of LRRK2 and its kinase activity in the regulation of PINK1/Parkin-dependent mitophagy, and evaluated the consequence of the G2019S substitution, both in a cell line (COS7) and in primary fibroblasts from PD patients. In particularly, we studied the impact of LRRK2 on the regulation of protein-protein interactions essential for mitophagy initiation. We also compared the efficiency of PINK1/Parkin-dependent mitochondrial clearance in familial PD forms linked to LRRK2 and PARK2. Our results show that LRRK2 and its LRRK2 G2019S variant delay mitophagy. Moreover, these proteins compromised key interactions involving Parkin and the GTPase dynamin related protein 1 (Drp1) on the outer mitochondrial membrane. We confirmed a defect in this process in fibroblasts from patients with PARK2 mutations and found a similar alteration in fibroblasts from patients with the G2019S substitution. Inhibition of LRRK2 kinase activity restored mitophagy induction in cells from LRRK2 patients, but not in cells from PARK2 patients. Altogether, these results highlight a role of LRRK2 and its pathogenic substitution in the regulation of PINK1/Parkin-dependent mitophagy.

Diversos estudos têm demonstrado que os danos causados pela exposição da pele à radiação ultravioleta (RUV) são relacionados aos fotodanos ao DNA, geração de espécies reativas de oxigênio e ativação de mediadores do processo inflamatório. Há, portanto, um crescente interesse pelo uso de antioxidantes com potencial fotoquimiopreventivo, como o extrato de maçã e a rutina. O modelo mais utilizado para avaliação de agentes fotoquimiovreventivos é a exposição de camundongos sem pelos à RUV. Porém, os esforços para diminuir ou mesmo evitar a utilização de animais em ensaios científicos tem levado a busca por métodos alternativos à experimentação animal. Na primeira etapa desse trabalho visou-se a otimização de parâmetros relativos ao processo de extração do pó da maçã, bem como a caracterização do extrato obtido e da rutina. Assim, as condições de extração da maçã otimizadas foram tempo de extração de 22 h, teor de etanol no solvente de 60 % (p/p) e proporção solvente:planta de 18 (p/p). A concentração dos ativos presentes na maçã levou ao extrato enriquecido com polifenóis da maçã (EEPM), que apresentou elevada atividade antioxidante in vitro e teor de rutina de 6,1 ± 0.3 ?g/g de extrato. Ambos os ativos apresentaram baixa ou nenhuma toxicidade contra os fibroblastos MRC5, bem como protegeram os fibroblatos contra a morte induzida pela RUV e inibiram a formação de peróxidos lipídicos gerados pelas células irradiadas no tratamento com 4000 e 100 ?g/mL de EEPM e rutina, respectivamente. Na segunda etapa desse trabalho visou-se a avaliação do potencial fotoquimiopreventivo do EEPM e da rutina adicionados a uma formulação tópica em modelos de biópsia de pele humana e pele humana reconstruída in vitro e de camundongo sem pelos in vivo. O EEPM (1,25 %) e a rutina (0,75 %) em formulação foram avaliados quanto à retenção cutânea in vitro utilizando célula de difusão vertical de Franz e, embora não tenha sido possível detectar compostos do EEPM, foi demonstrado que 2,04 ± 0,19 ?g/cm2 da rutina ficou retida na biópsia de pele humana. Na avaliação da eficácia fotoquimiopreventiva em modelos de pele humana in vitro o EEPM e a rutina adicionados em formulação foram capazes de evitar/diminuir a formação de sunburn cells, a indução de caspase-3, dímeros de ciclobutanodipirimidina, metaloproteinases e peroxidação lipídica em pele exposta à RUV. Quanto a atividade funcional in vivo, o extrato enriquecido com polifenóis da maçã apresentou leve efeito inibidor do infiltrado inflamatório induzido pela RUV, enquanto que tanto a rutina como o extrato inibiram a depleção dos níveis de GSH endógeno, o que sugere uma potente atividade fotoquimiopreventiva para estes princípios ativos. Estes resultados são promissores e apontam para o uso do EEPM e da rutina na prevenção/tratamento dos danos induzidos pela RUV na pele. / Several studies have shown that the ultraviolet radiation (UVR) - induced skin damage are related to DNA photolesions, generation of reactive oxygen species and activation of inflammatory mediators. Therefore, there is an increasing interest in the use of antioxidants with photochemoprotective potential, such as apple extract and rutin. The most used model for evaluation of photochemoprotective agents is the exposure of hairless mice to UVR. However, efforts to reduce or even avoid the use of animals in scientific trials has pursued for alternative methods to replace/reduce animal testing. The first step of this work aimed to optimize parameters for the extraction of apple powder and the characterization of the obtained extract and rutin. Thus, the optimized apple extraction conditions were extraction time of 22 h, ethanol content of 60% (w/w) and plant:solvent ratio of 18 (w/w). The apple extract concentration led to an enriched apple polyphenols extract (EEPM), which showed strong in vitro antioxidant activity and rutin content of 6.1 ± 0.3 ?g / g. The actives showed low or no toxicity against MRC5 fibroblasts, protected these cells against UVR - induced death and inhibited lipid peroxidation in irradiated cells (treatment with 4000 and 100 ?g/mL of EEPM and rutin, respectively). The second step of this study aimed to evaluate the photochemoprotective potential of EEPM and rutin added in a topical formulation and assayed in in vitro models of human skin biopsy and human reconstructed skin and in vivo hairless mouse. The EEPM (1.25%) and rutin (0.75%) formulations were evaluated for skin retention in vitro using the Franz diffusion cell and, although it was not possible to detect compounds of EEPM, rutin was retained in the human skin biopsy (2.04 ± 0.19 mg/cm2). As regard the The photochemoprotective efficacy in in vitro models of human skin, EEPM and rutin formulations were able to prevent/reduce the formation of sunburn cells, induction of caspase-3, cyclobutane pyrimidine dimers, matrix metalloproteinases and lipid peroxidation in skin exposed to UVR. As for in vivo functional activity, EEPM showed a slight inhibitory effect of UVR-induced inflammatory infiltrate, while both EEPM and rutin completely inhibited endogenous GSH levels depletion. These results are promising and suggest the use of EEPM and rutin in the prevention/treatment of ultraviolet radiationinduced damage to the skin.

Depuis plus d’une cinquantaine d’années, de formidables avancées ont été initiées dans le domaine de l’ingénierie tissulaire cutanée menant à la reconstruction in vitro de substituts de peau. La plupart sont des substituts dermiques destinés à être utilisés comme aide à la cicatrisation des plaies aigües et chroniques en complément des traitements de greffes conventionnels ainsi que pour l’augmentation des tissus mous. Bien qu’un nombre croissant de patients aient pu bénéficier de ces matrices dermiques, leur application clinique reste encore restreinte, en raison de leur coût élevé mais également à cause de résultats cicatriciels parfois peu satisfaisants. Par conséquent, il reste un défi de taille, celui de développer des substituts dermiques stimulant activement la cicatrisation, présentant un faible coût de production, sans propriétés antigéniques et possédant des propriétés mécaniques adaptées. Dans ce cadre, les hydrogels à base de fibrine constituent des candidats prometteurs, en particulier en raison du rôle central de cette protéine dans la cicatrisation. Le principal inconvénient est qu’à concentration physiologique, ces hydrogels sont faibles mécaniquement, ce qui les rend difficilement manipulables. L’objectif de cette thèse a été la mise au point ainsi que la caractérisation de différents hydrogels destinés à être utilisés comme substituts dermiques. Ces derniers présentent l’avantage d’associer les propriétés biologiques de la fibrine avec les propriétés mécaniques d’un polymère synthétique, le polyéthylène glycol dans une architecture de réseaux interpénétrés de polymères (RIP). Les résultats obtenus ont permis : - de confirmer les propriétés physico-chimiques des RIP développés initialement par nos collaborateurs de l’université de Cergy-Pontoise, - de valider en trois étapes (in vitro, ex vivo puis in vivo) la biocompatibilité de ces nouvelles matrices, destinées à être utilisées comme supports de culture 2D et pour l’augmentation des tissus mous, - d’élaborer et de caractériser des matrices macroporeuses, optimisées pour la culture 3D de fibroblastes de dermes humains. / Over the past five decades, we assisted in extraordinary advances in the field of skin tissue engineering which led to the in vitro reconstruction of a wide range of skin substitutes. Most of them are dermal substitutes: Their clinical application ranges from treating acute and chronic wounds to soft tissue augmentation. Although increasing numbers of patients have been treated with dermal substitutes, their clinical application has been limited by their substantial cost and some poor healing outcomes. Hence, there is still a challenge to produce a dermal substitute which enhance sufficiently wound healing. To this end, the substitute should exhibit suitable properties for enabling the repair process. Other requirements such as excellent biocompatibility, minimal antigenicity, ease to handle and cost-effective production are also essential. In this context, fibrin hydrogels constitute promising candidates for skin tissue engineering since fibrin fibers form a physiological and provisional backbone during wound healing. However, the poor mechanical properties of fibrin-based hydrogels at physiological concentration are an obstacle to their use. In this study, our aim was to design and characterize mechanically reinforced fibrin-based hydrogels by combining the intrinsic properties of a fibrin network with the mechanical features of a polyethylene glycol network using an interpenetrating polymer network (IPN) architecture. They are intended to be used as dermal scaffolds. The results obtained in this thesis: - Confirmed the suitable physico-chemical properties of IPN, first developed by our partner of the University of Cergy-Pontoise. - Validated their biocompatibility using a three-step approach (in vitro, ex vivo and in vivo assays). - Led to the synthesis and characterization of a new type of fibrin-based macroporous matrices, optimized for 3D dermal fibroblast culture.

L'optimisation des états de surface constitue un enjeu majeur pour les biomatériaux utilisés dans le domaine biomédical. Le titane (Ti) et ses alliages à base de nickel (NiTi) restent à ce jour les biomatériaux métalliques de prédilection dans nos applications cliniques en Odontologie (implants dentaires, instruments endodontiques, et arcs orthodontiques). Le but de nos recherche est d'optimiser les surfaces du Ti et NiTi en les fonctionnalisant par des films multicouches de polyélectrolytes (FMP). Notre travail propose d'étudier différents paramètres devant être impérativement validés avant d'envisager une quelconque application biomédicale in vivo avec ce type de revêtement. Une recherche bibliographique exhastive appuie notre recherche expérimentale. Le premier axe du travail propose de déterminer si des FMP peuvent effectivement s'adsorber chimiquement sur le Ti et le NiTi. qui plus est, une étude biologique est réalisée avec des cellules humaines pour tester la biocompatibilité des ces surfaces fonctionnalisées. La deuxième partie se concentre sur la biocompatibilité de la couche précurseur des FMP à base de polyéthyléneimine (PEI). Les résultats mettent en lumière une certaine cytotoxicité de la PEI envers des ostéoblastes et des fibroblastes gingivaux humain. Pour clore ce travail, nous réalisons des essais de stérilisation afin d'évaluer l'influence d'un tel procédé sur les FMP en terme de caractérisations physico-chimique et biologique des surfaces. La perspective d'une application biomédicale avec les FMP semble prometteuse, notamment en y introduisant des molécules bioactives. Cependant, bien d'autres paramètres sont encore à étudier avant d'envisager une application expérimentale et/ou clinique in vivo. Nous pouvons citer par exemple, le vieillissement des FMP, leur comportement en milieu salivaire ou fluoré, ou encore leur résistance à l'usure. Ces différents éléments rentrent dans les perspectives d'un projet post-doctoral. / Optimization of surface properties is a fundamental priority for biomaterials uses in biomedical applications. Titanium (Ti) and nickel-titanium alloys (NiTi) are the references in terms of metallic biomaterials for clinical applications in Odontology (Dental implants, endodontic instrumentations, and orthodontic arches). The aim of our work is to study the Ti and NiTi surfaces coated with polyelectrolytes multilayers films (PEM). Our work study various parameters needed to be validated before using this functionalized surface treatment for biomedical and clinical applictions in vivo. The first part of this work aims at defining the possibility to chemically adsorb PEM coating on Ti and on NiTi surfaces. Moreover, we have realized a biological study with human cells to test the biocompatibility of functionalized surfaces. In the second part of this thesis, we tested the biocompatibility of the multilayered structure in regards to the precursor base layer of PEM, the polyethyleneimine (PEI). Our reuslts show that the PEI is not cytotoxic towards osteoblasts and human gingival fibroblasts. Finally, we relaized tests of sterilization to evaluate PEM stability in terms of physico-chemical and biological surface characterizations. The development of specific biomedical applications for PEM is an exciting perspective, especially when these firms are functionalized with bioactive molecules. However, many other parameters murst be studied before imagining an experimental or clinical application in vivo. As an example, PEM degradation as well as behaviour in salivary or fluoride solution, still needs to be tested.